After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate
I'm only making one big prediction this year: The five-year party which saw biotech stocks outperform the broader markets comes to an end in 2016.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.